Stella H. Park
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Stella H. Park has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- David A. Knowles
New York Genome Center, New York, USA
3 shared publications - Megan D. Schertzer
Department of Molecular Physiology and Biological Physics, University of Virginia, Charlottesville, Virginia, 22903, US
3 shared publications - Gloria M. Sheynkman
Department of Molecular Physiology and Biological Physics, University of Virginia , Charlottesville, VA 22903
2 shared publications - Jiayu Su
Program for Mathematical Genomics Columbia University New York NY USA
2 shared publications Aline Réal
New York Genome Center, New York, NY, USA
1 shared publicationAndrew Stirn
New York Genome Center, New York, NY, USA
1 shared publication
Latest Publications
- Open Access
- 5 January 2026
- Published by Springer Nature in Nature Biotechnology
Mapping isoforms and regulatory mechanisms from spatial transcriptomics data with SPLISOSM
Transcript diversity including splicing and alternative 3′ end usage is crucial for cellular identity and adaptation, yet its spatial coordination remains poorly understood. Here we present SPLISOSM (spatial isoform statistical modeling), a method for detecting isoform-resolution patterns from spatial transcriptomics data. SPLISOSM uses multivariate testing with nonparametric kernels to account for spot-level and isoform-level dependencies, achieving high statistical power on sparse data. In the mouse brain, we identify over 1,000 spatially variable transcript diversity events, primarily in synaptic signaling pathways linked to neuropsychiatric disorders, and uncover both known and previously unknown regulatory relationships with region-specific RNA binding proteins. We further show that these patterns are evolutionarily conserved between mouse and human prefrontal cortex. Analysis of human glioblastoma highlights pervasive transcript diversity in antigen presentation and adhesion genes associated with specific microenvironmental conditions. Together, we present a comprehensive spatial splicing analysis in the brain under normal and neoplastic conditions.
- 5 January 2026
- Published by Springer Nature in Nature Biotechnology
Open AccessMapping isoforms and regulatory mechanisms from spatial transcriptomics data with SPLISOSM
Transcript diversity including splicing and alternative 3′ end usage is crucial for cellular identity and adaptation, yet its spatial coordination remains poorly understood. Here we present SPLISOSM (spatial isoform statistical modeling), a method for detecting isoform-resolution patterns from spatial transcriptomics data. SPLISOSM uses multivariate testing with nonparametric kernels to account for spot-level and isoform-level dependencies, achieving high statistical power on sparse data. In the mouse brain, we identify over 1,000 spatially variable transcript diversity events, primarily in synaptic signaling pathways linked to neuropsychiatric disorders, and uncover both known and previously unknown regulatory relationships with region-specific RNA binding proteins. We further show that these patterns are evolutionarily conserved between mouse and human prefrontal cortex. Analysis of human glioblastoma highlights pervasive transcript diversity in antigen presentation and adhesion genes associated with specific microenvironmental conditions. Together, we present a comprehensive spatial splicing analysis in the brain under normal and neoplastic conditions.
- Open Access
- 29 July 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 6948
Cas13d-mediated isoform-specific RNA knockdown with a unified computational and experimental toolbox
Pre- and post-transcriptional mechanisms, including alternative promoters, termination signals, and splicing, play essential roles in diversifying protein output by generating distinct RNA and protein isoforms. Two major challenges in characterizing the cellular function of alternative isoforms are the lack of experimental methods to specifically and efficiently modulate isoform expression and computational tools for complex experimental design and analysis. To address these gaps, we develop and methodically test an isoform-specific knockdown strategy which pairs the RNA-targeting CRISPR/Cas13d system with guide RNAs that span exon-exon junctions. In parallel, we provide computational tools for experimental design and analysis. In this study, we demonstrate that junction-targeting achieves robust and isoform-specific RNA knockdown across diverse alternative isoform events, genes, and cell types.
- 29 July 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 6948
Open AccessCas13d-mediated isoform-specific RNA knockdown with a unified computational and experimental toolbox
Pre- and post-transcriptional mechanisms, including alternative promoters, termination signals, and splicing, play essential roles in diversifying protein output by generating distinct RNA and protein isoforms. Two major challenges in characterizing the cellular function of alternative isoforms are the lack of experimental methods to specifically and efficiently modulate isoform expression and computational tools for complex experimental design and analysis. To address these gaps, we develop and methodically test an isoform-specific knockdown strategy which pairs the RNA-targeting CRISPR/Cas13d system with guide RNAs that span exon-exon junctions. In parallel, we provide computational tools for experimental design and analysis. In this study, we demonstrate that junction-targeting achieves robust and isoform-specific RNA knockdown across diverse alternative isoform events, genes, and cell types.
- Open Access
Perplexity as a Metric for Isoform Diversity in the Human Transcriptome
Characterizing the extensive isoform diversity revealed by long-read RNA-sequencing remains challenging. After removal of technical artifacts, existing pipelines apply arbitrary expression thresholds that filter out bona fide transcript structures, misrepresenting diversity and hindering reproducibility. Instead of discarding isoforms, we propose a fundamentally distinct approach to quantifying isoform diversity using perplexity –the effective number of isoforms for a gene, derived from Shannon entropy–wherein every isoform, including low-abundance ones, contributes proportionally to a gene’s diversity. Analyzing 124 ENCODE4 PacBio datasets spanning 55 human cell types, we show that perplexity provides interpretable and reproducible isoform diversity measurements across genes, regulatory levels, and tissues.
Open AccessPerplexity as a Metric for Isoform Diversity in the Human Transcriptome
Characterizing the extensive isoform diversity revealed by long-read RNA-sequencing remains challenging. After removal of technical artifacts, existing pipelines apply arbitrary expression thresholds that filter out bona fide transcript structures, misrepresenting diversity and hindering reproducibility. Instead of discarding isoforms, we propose a fundamentally distinct approach to quantifying isoform diversity using perplexity –the effective number of isoforms for a gene, derived from Shannon entropy–wherein every isoform, including low-abundance ones, contributes proportionally to a gene’s diversity. Analyzing 124 ENCODE4 PacBio datasets spanning 55 human cell types, we show that perplexity provides interpretable and reproducible isoform diversity measurements across genes, regulatory levels, and tissues.